PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma
- Status
- UNKNOWN
- Phase
- NA
Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Surgical Excision Margins in Thick Primary Melanoma - 2
- Status
- COMPLETED
- Phase
- NA
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients
- Status
- COMPLETED
- Phase
- NA
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease
- Status
- COMPLETED
- Phase
- PHASE2
Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab and EDP1503 in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of CDX-3379, a Human Monoclonal Antibody Targeting ERBB3, in Combination With the MEK Inhibitor, Trametinib, in Patients With Advanced Stage NRAS Mutant and BRAF/NRAS Wildtype (WT) Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE1